脾脏对脂多糖诱导炎症时循环成纤维细胞生长因子23升高有显著贡献
在健康人和不同分期慢性肾脏病患者中分析循环FGF23与炎症细胞因子的相关性,并在正常小鼠中给予急性、慢性持续、慢性间歇或慢性持续叠加急性低剂量脂多糖暴露,检测血液和实体器官FGF23表达。结果显示FGF23与中性粒细胞明胶酶相关脂质运载蛋白、C反应蛋白、肿瘤坏死因子-α、白细胞介素-6显著相关;急性叠加慢性脂多糖暴露升高组织FGF23 mRNA及循环cFGF23和iFGF23,脾脏是FGF23的主要来源。
要点
- 循环FGF23与中性粒细胞明胶酶相关脂质运载蛋白(r=0.72,P<0.001)、C反应蛋白(r=0.38,P<0.001)、肿瘤坏死因子-α(r=0.32,P=0.001)、白细胞介素-6(r=0.48,P<0.001)显著相关。
- 急性脂多糖给药升高组织FGF23 mRNA和血浆cFGF23,但不升高iFGF23。
- 慢性持续或慢性间歇脂多糖均未升高组织或循环FGF23;急性叠加慢性脂多糖升高组织FGF23 mRNA及循环cFGF23和iFGF23,脾脏是FGF23的主要来源。
核心结论
- 在正常小鼠炎症模型中,急性叠加慢性脂多糖暴露刺激FGF23产生。
- 首次提供证据表明在此条件下脾脏对循环FGF23水平升高有显著贡献。
研究设计与样本
- 在健康受试者和不同水平慢性肾脏病患者中分析循环FGF23与炎症细胞因子的相关性。
- 在正常小鼠中给予急性(一次)或慢性(2周)低剂量脂多糖暴露,慢性暴露分为持续(皮下埋植)、间歇(每日注射)或持续叠加急性(皮下埋植加处死当天急性注射)。
- 检测血液中全段(cFGF23)和完整(iFGF23)FGF23水平,实体组织用免疫组化、酶联免疫吸附测定和逆转录聚合酶链反应检测。
主要发现
- FGF23与中性粒细胞明胶酶相关脂质运载蛋白(r=0.72,P<0.001)、C反应蛋白(r=0.38,P<0.001)、肿瘤坏死因子-α(r=0.32,P=0.001)、白细胞介素-6(r=0.48,P<0.001)显著相关。
- 急性脂多糖给药升高组织FGF23 mRNA和血浆cFGF23水平,但不升高iFGF23。
- 慢性持续或慢性间歇脂多糖均未升高组织或循环FGF23水平。
- 急性叠加慢性脂多糖升高组织FGF23 mRNA以及循环cFGF23和iFGF23水平。
- 脾脏是FGF23的主要来源。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Circulating levels of fibroblast growth factor 23 (FGF23) increase progressively and correlate with systemic inflammation in chronic kidney disease (CKD). The aim of this study was to identify and characterize the causal relationship between FGF23 and inflammation in CKD. METHODS: Circulating FGF23 and inflammatory cytokines were correlated in healthy subjects and patients with varying levels of CKD. In addition, FGF23 expression in blood and solid organs was measured in normal mice that were exposed acutely (one time) or chronically (2-week) to low-dose lipopolysaccharide (LPS); chronic exposure being either sustained (subcutaneous pellets), intermittent (daily injections) or combined sustained plus acute (subcutaneous pellets plus acute injection on the day of sacrifice). Blood was analyzed for both terminal (cFGF23) and intact (iFGF23) FGF23 levels. Solid tissues were investigated with immunohistochemistry, enzyme-linked immunosorbent assay and reverse transcription polymerase chain reaction. RESULTS: FGF23 levels correlated significantly with neutrophil gelatinase-associated lipocalin ( r = 0.72, P < 0.001), C-reactive protein ( r = 0.38, P < 0.001), tumor necrosis factor-α ( r = 0.32, P = 0.001) and interleukin-6 ( r = 0.48, P < 0.001). Acute LPS administration increased tissue FGF23 mRNA and plasma levels of cFGF23 but not iFGF23. Neither chronic sustained nor chronic pulsatile LPS increased the tissue or circulating levels of FGF23. However, acute on chronic LPS raised tissue FGF23 mRNA and both circulating cFG23 and iFGF23. Interestingly, the spleen was the major source of FGF23. CONCLUSION: Acute on chronic exposure to LPS stimulates FGF23 production in a normal mouse model of inflammation. We provide the first evidence that the spleen, under these conditions, contributes substantially to elevated circulating FGF23 levels.
引用
- Bansal S, Friedrichs WE, Velagapudi C, et al. Spleen contributes significantly to increased circulating levels of fibroblast growth factor 23 in response to lipopolysaccharide-induced inflammation. Nephrol Dial Transplant. 2017. PMID: 27836924. doi:10.1093/ndt/gfw376
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。